Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. - Wikidata - wikimedia - TriplyDB

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study.

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study.

http://www.wikidata.org/entity/Q35620231

about

Risk of cancer in diabetes: the effect of metformin Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Diabetes mellitus and metformin in hepatocellular carcinoma Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis From obesity to diabetes and cancer: epidemiological links and role of therapies Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review Metformin and the risk of cancer: time-related biases in observational studies Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis Metformin in obesity, cancer and aging: addressing controversies Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Effect of metformin on prostate cancer outcomes after radical prostatectomy Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Metformin and cancer.Glargine safety, diabetes and cancer.Metformin and breast cancer risk: a meta-analysis and critical literature review.Metformin in cancer prevention and therapy.Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.The effect of metformin on breast cancer outcomes in patients with type 2 diabetes Metformin and breast and gynecological cancer risk among women with diabetes.Chemopreventive strategies in hepatocellular carcinoma Reduction behavior induced by HL010183, a metformin derivative against the growth of cutaneous squamous cell carcinoma.Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator.Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.Metformin and its clinical use: new insights for an old drug in clinical practice.When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.

P2860

Q21284807-59B632AE-E14D-46C5-8FDF-98E90CE884CC Q24745996-21A60DD6-502E-48BC-B76A-BC79BEFB77E2 Q26741205-D1EC0C20-D2D6-449E-A4D5-91C4DA707FA5 Q26750845-E1F146EA-EE18-4616-88DD-1309DB06107E Q26765139-80FCB961-64A6-4EDE-8EAC-1CE96E989F08 Q26767027-7F4F817B-ECFC-43A1-A471-38A339B0B48B Q26850912-AA2D2507-332C-44EE-9C3E-941A52458D1D Q26999266-872F4C19-4F70-485C-B17C-0D94384DE994 Q27025309-9A145009-9776-4167-92EA-D6874D37FF3E Q28069605-97C80AB7-F8B8-4028-A668-425A3021925B Q28480735-C6534498-51F9-4D82-9939-337CA77D7C0A Q28484435-804E00CD-E119-4AA7-B954-94EBAEB31381 Q28535372-2D9ABD81-6998-44F1-8A7F-BA531603941E Q28542914-969ADEBA-22B4-48E5-9387-4FA318E2A395 Q30234736-09A67EEF-F0AB-430E-8DA5-29F0642F7212 Q33551333-C6AD1E12-6C43-4F66-A65D-8C28712090BC Q33672932-3A415C8D-4B6F-498D-8EB6-61C373BDFF7F Q33702357-7D1D5C08-3962-4326-AD3C-83842F38C2A0 Q33748862-FEE52B3C-D094-43E5-AB14-B334B3E2E87B Q34135248-85A61B43-6C31-46EC-ABBD-A985925334C6 Q34159241-10DB4FB8-497A-4985-ADD4-9B31CFBEEE8B Q34326924-CE24713F-A16D-4C14-BB87-E608784A16D0 Q34357389-FFE27B13-67C6-49E6-B534-90282CE3FE57 Q34357983-7898B55D-ADD5-4686-9C6A-F1BC2BDE24AD Q34438700-5D8E3579-26D1-441C-9CE3-848E3954162B Q34584370-BD77376B-D30A-4B1C-BB76-96349834D24A Q34998627-7358D98E-D2CE-45BB-9D69-6E637569BD57 Q35000522-6E39337C-11B0-4FEA-B034-D8FB264A0F88 Q35046074-BB0CB766-D2CF-4486-8F92-0E15D8113FF7 Q35101365-E23DC4D1-D87F-4461-B4C5-4A8192A45D84 Q35145204-28D5EA0F-C112-46E8-BD0D-2811568F3B81 Q35678036-397C8FAC-AC3C-4F9E-9991-0A4DC2D5CCF3 Q35782187-79F161B9-641C-423C-9BDD-440D75D1EE2D Q36024628-34B0BF55-73AA-402C-A398-2B6F385C4ED7 Q36136847-09D88F24-FCD5-442C-8C7C-03D5B0AB5BC3 Q36182935-3704B6D1-F5C5-473A-B12E-66CD9089B211 Q36370966-A450A4AA-40B6-458D-8B61-57426EB7EB64 Q36423076-B989740C-960B-4F4F-8CB8-5A1A8365A7BA Q36442945-5582FE31-2F7D-41C3-8FA0-F9DD4F4EC1BE Q36523427-1F7AE2E2-58D7-4ED5-AAAB-5E2FA8F6121E

P2860

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study.

http://www.wikidata.org/entity/Q35620231

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Lower risk of cancer in patien ...... ulation-based follow-up study.

@ast

Lower risk of cancer in patien ...... ulation-based follow-up study.

@en

type

label

Lower risk of cancer in patien ...... ulation-based follow-up study.

@ast

Lower risk of cancer in patien ...... ulation-based follow-up study.

@en

prefLabel

Lower risk of cancer in patien ...... ulation-based follow-up study.

@ast

Lower risk of cancer in patien ...... ulation-based follow-up study.

@en

P1433

Q35620231-ADBA4415-39FC-4830-9CA2-38591B25C85D

P1476

Q35620231-94F7C464-E2C7-4877-A7C4-4E223AD26C3E

P2093

Q35620231-38625A3A-29B6-4CA1-B200-91EA6DFBDE04

Q35620231-41097AA9-191D-4C6A-AFD2-6A806370CD1A

Q35620231-8A59DAE1-8D94-4EF2-B07B-DC796352969D

Q35620231-98D68D9E-C600-46C0-A2E4-DD587723F542

Q35620231-AB2A89A1-3FDE-488A-9C14-3ADB9633311B

Q35620231-B6D239DF-C97E-4049-B63A-10642E298248

Q35620231-CC34074F-46A1-4021-AF7C-AED3F6334749

Q35620231-D8BDF8AA-60B0-4F12-87BA-D8B0F7B8A55A

Q35620231-E4788227-A255-4BF9-A88A-3D0702AEB87A

P2860

Q35620231-17BBEFEE-899A-4264-8080-A3C627073D1F

Q35620231-285D2778-A712-41D9-ACC1-3089612E184E

Q35620231-4E51E168-53F3-4100-A47B-26BD0F24B8A3

Q35620231-5D141F10-D8AF-4519-AC8F-F88A76FC6744

Q35620231-634FCAAC-AB39-486A-90AB-4673E1D8FCFC

Q35620231-64DD93C3-AA7B-4B67-A405-66959295AFDD

Q35620231-6521BC1C-50AA-4B20-8BE6-80D53F507321

Q35620231-69B1D9B0-32C5-4AE0-9036-3D6A145F097B

Q35620231-6DF3B6A3-E169-43B4-B905-0001236766D0

Q35620231-8A9EE3C1-9A78-4D8C-9CA3-20E5234FB47D

P304

Q35620231-86F6C02B-3026-451B-B619-16685E09D418

P31

Q35620231-CC6594A5-5DB7-4C00-AFEC-657CA5251047

P356

Q35620231-A0B075D9-4F22-4025-B505-0B8C26B3DF63

P407

Q35620231-B6139CC0-46E6-48A1-85C0-2C8053689A1C

P433

Q35620231-17436A10-329E-42A2-A74F-2D412367ABC7

P478

Q35620231-95A5B2C1-234E-4077-A80A-68ECBE3BC7E1

P577

Q35620231-F81679E3-AA9D-4113-847B-0E821CDC4DDB

P5875

Q35620231-1416445F-1AAE-4689-93AC-5965EB6D4B99

P698

Q35620231-A623A9A0-56BE-4A72-8EC2-B35C7EA73213

P921

Q35620231-531CB82F-342B-4747-AC3E-6D5D444A086E

P932

Q35620231-8F6B67F3-973C-4E59-BF7D-75462B398353

P356

P1433

P1476

Lower risk of cancer in patien ...... ulation-based follow-up study.

@en

P2093

Bruno H Ch Stricker

http://www.w3.org/2001/XMLSchema#string

Harm R Haak

http://www.w3.org/2001/XMLSchema#string

Jan-Willem W Coebergh

http://www.w3.org/2001/XMLSchema#string

Loes E Visser

http://www.w3.org/2001/XMLSchema#string

Myrthe P P van Herk-Sukel

http://www.w3.org/2001/XMLSchema#string

Petronella H Geelhoed-Duijvestijn

http://www.w3.org/2001/XMLSchema#string

Rikje Ruiter

http://www.w3.org/2001/XMLSchema#string

Ron M C Herings

http://www.w3.org/2001/XMLSchema#string

Sabine M J M Straus

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes and cancer: a consensus report.

Metformin and reduced risk of cancer in diabetic patients

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

Long-term metformin use is associated with decreased risk of breast cancer.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.

Sulphonylureas and cancer: a case-control study.

P304

119-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-0857

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51815202

http://www.w3.org/2001/XMLSchema#string

P698

22100960

http://www.w3.org/2001/XMLSchema#string

P921

P932

3241334

http://www.w3.org/2001/XMLSchema#string